24 results
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
Company measures are not presented in the Pay versus Performance table. Moreover, the Company generally seeks to incentivize long-term performance
DRS
wrc48 k8l2129
15 May 20
Draft registration statement
12:00am
10-K
g69w62knnub bjjfrksq
16 Mar 20
Annual report
5:17pm
10-Q
yv1uspsq2r
12 Aug 19
Quarterly report
7:17am
424B4
ru19u5x24 hrk7f9y5a
20 Jun 19
Prospectus supplement with pricing info
5:20pm
S-1/A
ido0yvhcnhm wxrpawy
10 Jun 19
IPO registration (amended)
11:16am